Literature DB >> 2993672

Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer.

G Pizzocaro, R Salvioni, F Zanoni.   

Abstract

Bilateral retroperitoneal lymphadenectomy is mainly a staging procedure in patients with stage I nonseminomatous testis cancer, and it causes permanent loss of antegrade ejaculation in approximately two-thirds of the cases. Between May 1978 and August 1981, 61 consecutive patients with no intraoperative evidence of lymph node involvement underwent unilateral retroperitoneal lymph-adenectomy for nonseminomatous germinal testis tumors. Microscopic metastases were found in 1 to 4 retroperitoneal nodes in 6 cases (9.8 per cent). Antegrade ejaculation was absent postoperatively in 11 patients (18 per cent), with no significant difference between patients who underwent lymph node dissection on the left or right side. Ejaculation returned spontaneously in 3 patients, 1 of whom fathered a child. The disease recurred in 10 patients 3 to 35 months after lymphadenectomy (median 6 months). Disease recurred in 8 of 55 patients (14.5 per cent) with negative nodes and 2 of 6 (33.3 per cent) with positive histological findings. No patient suffered retroperitoneal recurrence. The more than 3-year survival rates free of disease were 96.4 and 83.3 per cent in patients with pathological stages I and II disease, respectively. Unilateral retroperitoneal lymphadenectomy in patients with intraoperative stage I nonseminomatous germinal testis cancer preserves antegrade ejaculation in more than 80 per cent of the cases without apparently compromising the long-term survival.

Entities:  

Mesh:

Year:  1985        PMID: 2993672     DOI: 10.1016/s0022-5347(17)47252-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates.

Authors:  Mark H Katz; Scott E Eggener
Journal:  World J Urol       Date:  2009-04-11       Impact factor: 4.226

Review 2.  Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.

Authors:  Shane Pearce; Zoe Steinberg; Scott Eggener
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

3.  Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.

Authors:  G Pizzocaro; N Nicolai; R Salvioni
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

5.  Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.

Authors:  Joseph A Pettus; Brett S Carver; Timothy Masterson; Jason Stasi; Joel Sheinfeld
Journal:  Urology       Date:  2008-11-20       Impact factor: 2.649

6.  Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection.

Authors:  K D Jacobsen; S Ous; H Waehre; H Trasti; A E Stenwig; H H Lien; N Aass; S D Fosså
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 7.  The Use of Modified Templates in Early and Advanced Stage Nonseminomatous Germ Cell Tumor.

Authors:  Timothy A Masterson; Clint Cary
Journal:  Adv Urol       Date:  2018-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.